Release date: 2018-03-28
When Liron Elia founded Art Medical in 2009, he had a goal: to prevent pneumonia in patients in the intensive care unit. In the past nine years, the company's mission has been enriched: its products seek to prevent complications from intubation, including aspiration pneumonia, ventilator-associated pneumonia, and acute kidney injury. Optimized enteral feeding is also the company. Research direction.
The company, which has branches in Israel and Palo Alto, California, specializes in sensor intubation (smART feeding tubes) and its technology platform (smART console).
In a telephone interview, Elia said: "Overall, what we do is to mount the sensor on a general cannula and instrument, and let the intubation device become real-time communication between the sensor and the smart terminal. intelligent."
Complications such as aspiration pneumonia, ventilator-associated pneumonia, and acute kidney injury can prolong hospital stay and increase the risk of death. In order to reduce this type of risk, the hospital has to monitor the patient's gastroesophageal reflux and saliva in order to diagnose in time for complications.
Art Medical wants to streamline this process. Smart intubation automatically monitors and collects data. Through the smart terminal, the nurse can monitor this information in real time and then further intervene after discovering the situation.
Elia said: "After the patient has been in the ventilator and is anesthetized, you don't know if he is inhaling, but the sensor can help us monitor these situations in real time."
The startup's technology has been approved by the European Qualifications and the US Food and Drug Administration. Elia said that these technologies are now undergoing clinical trials in the United States.
This technology platform only focuses on monitoring complications in critically ill patients. For example, for a patient admitted to a stroke, Art Medical's system does not monitor the patient's own stroke, but instead focuses on the complications caused by subsequent intubation.
This is also one of the original intentions of Elia to create this company. He had seen a patient hospitalized for a stroke. Although the stroke had recovered, he was in the hospital because of pneumonia. This case prompted Elia to be determined to start the company.
In the summer of 2017, Art Medical took $20 million from an investor led by AMT (Advanced Medical Technologies).
Elia said: "This 20 million US dollars will help us put the perfect products on the market. I expect that our products will be listed at the end of the year. From 2019, the market will fully accept our products and realize that we are Help patients reduce the value of staying in the critically ill room."
Original source: medcitynews.com
Source: Health
Water Soluble Kiwi Fruit Powder,Kiwi powder food grade,Indian Ginseng Extract
Fufeng Sinuote Biotechnology Co.,Ltd. , https://www.sntbiology.com